Cell-culture (3T3-L1 adipocytes) 5-Amino-1MQ at 30 M strongly reduced 1-MNA levels in mouse fat cells, confirming NNMT inhibition (Neelakantan et al., Biochemical Pharmacology, 2018)
The 250500 mcg subcutaneous range used in current research contexts sits below the 1 mg clinical trial dose, partly because subcutaneous bioavailability differs from the oral administration used in some trial arms
Mechanism snapshot Positioned within NNMT inhibitor-class research for metabolic and methylation-linked pathways, distinct from NMN replacement biology
The combination with hyaluronic acid (6 mg) in the rabbit model produced superior outcomes to either compound alone, which has led some practitioners to explore AOD-9604 in joint health contexts
Cycling Approach: Some practitioners implement protocols such as 12 weeks on, 4-8 weeks off to theoretically prevent receptor desensitization, reduce long-term costs, or provide physiological breaks